Great news for Duke University and CVIT as they become partners of the new Research Triangle Center of Excellence in Regulatory Science and Innovation (Triangle CERSI), officially approved by the U.S. Food and Drug Administration (FDA). Duke University and the University of North Carolina at Chapel Hill joined together to create the new Center that will receive up to $50 million from FDA in the next five years. The Center also includes collaborations with North Carolina State University and North Carolina Central University. Triangle CERSI becomes the fifth Center in the U.S. operating under the FDA CERSI Program led by the Office of Regulatory Science and Innovation. The goal of the program is to promote innovation in regulatory science to support FDA’s regulatory science needs.
The Center for Virtual Imaging Trials will contribute to the new Triangle CERSI activities offering expertise and technologies for conducting human trials of imaging methods by applying virtual imaging techniques. Such tools developed by CVIT scientists, enable computational simulation comparisons with known ground truth and represent a unique resource in the current regulatory framework. In this scenario, “the Triangle CERSI is a significant opportunity for our scholarly communities to curate and direct our intelligence towards addressing an important societal need for proficient and efficient regulatory approval and oversight”, said Dr. Ehsan Samei, one of the three principal investigators from Duke University and CVIT Director.
The Center for Virtual Imaging Trials is proud to be part of the new Triangle CERSI.
